The Harvard School of Public Health (HSPH) is one of the professional graduate schools of Harvard University, located in the Longwood Medical Area of Boston, Massachusetts neighborhood of Mission Hill, which is next to Harvard Medical School. HSPH is considered a significant school focusing on health in the United States. Harvard School of Public Health grew out of the Harvard-MIT School for Health Officers, the nation's first graduate training program in population health, which was founded in 1913 and became Harvard School of Public Health in 1922. Julio Frenk, the Minister of Health of Mexico from 2000 to 2006 and a former executive director of the World Health Organization (WHO), became the new dean of HSPH in January 2009.
As one of the most selective and prestigious public health schools in the world, the middle 50 percent of the class that entered in 2006 had an incoming GPA between 3.50 and 3.75 (out of 4.0). About half of HSPH students already hold a medical doctorate (M.D. or D.O.), with many of the rest holding another advanced degree (typically a DPM, DDS/DMD, PhD, JD, or MBA). HSPH students are drawn from around the world, with about 40 percent of the student body coming from outside of the United States.
Overall, HSPH is ranked third after the University of North Carolina School of Public Health in the 2011, U.S. News & World Report. The Johns Hopkins Bloomberg School of Public Health was ranked first in the same report. U.S. News consistently ranks Harvard #1 in Health Policy and Management.
The following is the list of scholars from Harvard TH Chan School of Public Health who currently serve as editors for one or more SciTechnol journals.
The following is the list of articles by scholars from Harvard TH Chan School of Public Health that are published in SciTechnol journals.
Changes of Circulating Endothelial Cells and Microparticles after Conventional Chemotherapy in Patients with Extensive Small-Cell Lung Cancer: Relevance to Prognosis and Treatment ResponseResearch Article: J Clin Exp Oncol 2018, 7:5
Najjar F, Alammar M, Al- Massarani G, Almalla N, Japawe A, Banat I and Ikhtiar A
- Short Communication: J Clin Exp Oncol 2018, 7:5
Prognostic Factors for Survival in Patients with Hepatocellular Carcinoma Treated By Transarterial Chemoembolization Using Drug-Eluting BeadsResearch Article: J Clin Exp Oncol 2018, 7:5
Levasicc N, Lesnik LA, Garbajs M, Dezman R and Popovic P
- Perspective: J Clin Exp Oncol 2018, 7:5
- Case Report: J Clin Exp Oncol 2018, 7:5
Sanjay Kumar M and Praveen Kumar M
Circulating Levels of ADAM-10 and Soluble Standard CD44 in Patients with Hepatocellular Carcinoma: Relationship with Soluble TAM Receptors and their LigandsResearch Article: J Clin Exp Oncol 2018, 7:5
Soichiro Uehara, Yuichi Fukuzawa, Tomohiko Matuyama and Katuhiro Gotoh